Form 8.3 – WILLIS TOWERS WATSON PLC

LONDON–()– 

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1) Barclays PLC.
Company dealt in WILLIS TOWERS WATSON PLC
Class of relevant security to which the ORD
dealings being disclosed relate (Note 2)
Date of dealing 17 September 2020

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Class of relevant security: ORD
Long Short
Number (%) Number (%)

(1)

Relevant securities

2,218,597

1.72%

468,726

0.36%

 

(2)

Derivatives (other than options):

355,000

0.28%

388,524

0.30%

 

(3)

Options and agreements to
purchase/sell:

0

0.00%

0

0.00%

 
TOTAL:

2,573,597

2.00%

857,250

0.67%

 

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

 

 

 

(2) Derivatives (other than options)

 

 

 

(3) Options and agreements to purchase/sell

 

 

Total

 

 

 

1. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale Number of relevant securities Price per unit

Purchase

14

206.3800 USD

Purchase

17

204.3900 USD

Purchase

26

206.6250 USD

Purchase

26

205.4488 USD

Purchase

60

206.6200 USD

Purchase

100

206.5850 USD

Purchase

168

206.0525 USD

Purchase

188

206.3667 USD

Purchase

292

204.3400 USD

Purchase

371

206.6170 USD

Purchase

816

205.3210 USD

Purchase

1,224

205.1387 USD

Purchase

2,085

204.8674 USD

Purchase

2,135

205.7087 USD

Purchase

5,330

205.7100 USD

Purchase

6,174

205.5003 USD

Purchase

8,143

205.7011 USD

Purchase

16,035

205.5988 USD

Purchase

148,100

205.5981 USD

Sale

1

204.7100 USD

Sale

1

205.6500 USD

Sale

1

205.5600 USD

Sale

2

205.3200 USD

Sale

2

205.7600 USD

Sale

2

205.7150 USD

Sale

2

204.9950 USD

Sale

3

205.4800 USD

Sale

5

205.7300 USD

Sale

68

205.5910 USD

Sale

100

204.9600 USD

Sale

126

206.5933 USD

Sale

147

205.6602 USD

Sale

207

205.6965 USD

Sale

300

203.7300 USD

Sale

314

205.4769 USD

Sale

342

204.3400 USD

Sale

395

205.3053 USD

Sale

478

205.1349 USD

Sale

566

205.5767 USD

Sale

705

205.5470 USD

Sale

793

205.3470 USD

Sale

924

205.5961 USD

Sale

2,085

204.8674 USD

Sale

2,152

205.6983 USD

Sale

2,553

205.0451 USD

Sale

3,455

205.5684 USD

Sale

5,187

205.5543 USD

Sale

5,296

205.7100 USD

Sale

5,347

205.6660 USD

Sale

5,381

205.5228 USD

Sale

6,573

205.2690 USD

Sale

7,456

205.5483 USD

Sale

8,093

205.7095 USD

Sale

8,244

205.9150 USD

Sale

10,014

205.6683 USD

Sale

10,350

205.7737 USD

Sale

13,385

205.6412 USD

Sale

15,100

205.6128 USD

Sale

74,569

205.5754 USD

(b) Derivatives transactions (other than options transactions)

Product name,

e.g. CFD

Nature of transaction

(Note 6)

Number of relevant securities

(Note 7)

Price per unit

(Note 5)

 

 

 

 

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

 

 

 

 

 

 

 

(ii) Exercising

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

 

 

 

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

 

 

 

 

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None

Is a Supplemental Form 8 (Open Positions) attached?

NO

Date of disclosure:

18 Sep 2020

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

If a connected EFM, name of offeree/offeror with which connected

 

If a connected EFM, state nature of connection

 

 

Category Code: RET
Sequence Number: 713623
Time of Receipt (offset from UTC): 20200918T105312+0100

Leave a Reply

Your email address will not be published. Required fields are marked *